207 related articles for article (PubMed ID: 29534201)
1. In vitro activity of amphotericin B-azole combinations against Malassezia pachydermatis strains.
Álvarez-Pérez S; García ME; Blanco JL
Med Mycol; 2019 Feb; 57(2):196-203. PubMed ID: 29534201
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and genetic diversity of azole-resistant Malassezia pachydermatis isolates from canine otitis and dermatitis: A 2-year study.
Álvarez-Pérez S; Quevedo-Caraballo S; García ME; Blanco JL
Med Mycol; 2024 May; 62(5):. PubMed ID: 38734886
[TBL] [Abstract][Full Text] [Related]
3. Subculture on potato dextrose agar as a complement to the broth microdilution assay for Malassezia pachydermatis.
Prado MR; Brito EH; Brilhante RS; Cordeiro RA; Leite JJ; Sidrim JJ; Rocha MF
J Microbiol Methods; 2008 Oct; 75(2):341-3. PubMed ID: 18603321
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic characterization and in vitro antifungal sensitivity of Candida spp. and Malassezia pachydermatis strains from dogs.
Brito EH; Fontenelle RO; Brilhante RS; Cordeiro RA; Soares Júnior FA; Monteiro AJ; Sidrim JJ; Rocha MF
Vet J; 2007 Jul; 174(1):147-53. PubMed ID: 17188535
[TBL] [Abstract][Full Text] [Related]
5. Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values.
Cafarchia C; Iatta R; Immediato D; Puttilli MR; Otranto D
Med Mycol; 2015 Sep; 53(7):743-8. PubMed ID: 26162472
[TBL] [Abstract][Full Text] [Related]
6. Sequential exposure of Malassezia pachydermatis to azoles: enhanced or decreased activity?
Schlemmer KB; Jesus FP; Zanette RA; Zimmermann CE; Lautert C; Alves SH; Santurio JM
Vet Microbiol; 2014 Jun; 171(1-2):255-6. PubMed ID: 24786225
[No Abstract] [Full Text] [Related]
7. In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
Cafarchia C; Figueredo LA; Iatta R; Montagna MT; Otranto D
Vet Microbiol; 2012 Mar; 155(2-4):395-8. PubMed ID: 21962411
[TBL] [Abstract][Full Text] [Related]
8. High multi-azole-resistant Malassezia pachydermatis clinical isolates from canine Malassezia dermatitis.
Kano R; Aramaki C; Murayama N; Mori Y; Yamagishi K; Yokoi S; Kamata H
Med Mycol; 2020 Feb; 58(2):197-200. PubMed ID: 31329927
[TBL] [Abstract][Full Text] [Related]
9. Malassezia pachydermatis from animals: Planktonic and biofilm antifungal susceptibility and its virulence arsenal.
Brilhante RSN; Rocha MGD; Guedes GMM; Oliveira JS; Araújo GDS; España JDA; Sales JA; Aguiar L; Paiva MAN; Cordeiro RA; Pereira-Neto WA; Pinheiro AQ; Sidrim JJC; Castelo-Branco DSCM; Rocha MFG
Vet Microbiol; 2018 Jul; 220():47-52. PubMed ID: 29885800
[TBL] [Abstract][Full Text] [Related]
10. Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method.
Rojas FD; Sosa Mde L; Fernández MS; Cattana ME; Córdoba SB; Giusiano GE
Med Mycol; 2014 Aug; 52(6):641-6. PubMed ID: 24965946
[TBL] [Abstract][Full Text] [Related]
11. Multi-azole-resistant strain of Malassezia pachydermatis isolated from a canine Malassezia dermatitis.
Kano R; Yokoi S; Kariya N; Oshimo K; Kamata H
Med Mycol; 2019 Apr; 57(3):346-350. PubMed ID: 29800467
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo activity of a killer peptide against Malassezia pachydermatis causing otitis in dogs.
Cafarchia C; Immediato D; Paola GD; Magliani W; Ciociola T; Conti S; Otranto D; Polonelli L
Med Mycol; 2014 May; 52(4):350-5. PubMed ID: 24625672
[TBL] [Abstract][Full Text] [Related]
13. Genotyping and antifungal susceptibility testing of multiple Malassezia pachydermatis isolates from otitis and dermatitis cases in pets: is it really worth the effort?
Álvarez-Pérez S; García ME; Peláez T; Blanco JL
Med Mycol; 2016 Jan; 54(1):72-79. PubMed ID: 26333353
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of carvacrol, cinnamaldehyde and thymol combined with antifungals against Malassezia pachydermatis.
Schlemmer KB; Jesus FPK; Tondolo JSM; Weiblen C; Azevedo MI; Machado VS; Botton SA; Alves SH; Santurio JM
J Mycol Med; 2019 Dec; 29(4):375-377. PubMed ID: 31455580
[TBL] [Abstract][Full Text] [Related]
15. Antifungal susceptibility of Malassezia pachydermatis biofilm.
Figueredo LA; Cafarchia C; Otranto D
Med Mycol; 2013 Nov; 51(8):863-7. PubMed ID: 23834283
[TBL] [Abstract][Full Text] [Related]
16. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Oz Y; Akşit F; Kiraz N; Kiremitçi A
Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
[TBL] [Abstract][Full Text] [Related]
17. The role of drug efflux pumps in Malassezia pachydermatis and Malassezia furfur defence against azoles.
Iatta R; Puttilli MR; Immediato D; Otranto D; Cafarchia C
Mycoses; 2017 Mar; 60(3):178-182. PubMed ID: 27774659
[TBL] [Abstract][Full Text] [Related]
18. Azole and terbinafine susceptibility testing of Malassezia pachydermatis in Japan.
Murayama N; Kano R
J Vet Med Sci; 2023 Mar; 85(3):383-385. PubMed ID: 36724970
[TBL] [Abstract][Full Text] [Related]
19. Effects of beta-thujaplicin on anti-Malassezia pachydermatis remedy for canine otitis externa.
Nakano Y; Wada M; Tani H; Sasai K; Baba E
J Vet Med Sci; 2005 Dec; 67(12):1243-7. PubMed ID: 16397383
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of Malassezia pachydermatis isolates from canine skin with atopic dermatitis to ketoconazole and itraconazole in East Asia.
Watanabe S; Koike A; Kano R; Nagata M; Chen C; Hwang CY; Hasegawa A; Kamata H
J Vet Med Sci; 2014 Apr; 76(4):579-81. PubMed ID: 24334863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
